Radioligand Therapy in the Clinic

Real-world Experiences Associated with Treating Patients With Lutetium-177 PSMA in a High-volume Care Center - Thomas Hope

March 22, 2023

Details

Lutetium-617 - Treatment Sequencing Considerations for Metastatic Castration-Resistant Prostate Cancer - Neal Shore

October 16, 2022

Details

Imaging and PET Analysis as a Prognostic Tool for Lu-PSMA-617 Treatment in Patients with mCRPC - Phillip H. Kuo

October 16, 2022

Details

Integrating 177Lu-PSMA-617 in Clinical Practice - Oliver Sartor

July 4, 2022

Details

Methods for Preparation and Administration of Pluvicto™ (177Lu-PSMA-617) - Kendra Harris

May 10, 2022

Details

Preparing for Treatment with 177Lu-PSMA-617 - Kendra Harris

April 22, 2022

Details

Administering Pluvicto™ - A Patient Shares His Treatment Experience of 177Lu-PSMA-617 - Kendra Harris and Phillip Koo

April 22, 2022

Details

Integration of Pluvicto™ (177Lu-PSMA-617) in Clinical Practice - Oliver Sartor and Kendra Harris

April 7, 2022

Details

Radiation Safety and the Integration of Pluvicto™ (177Lu-PSMA-617) in Treatment of mCRPC- Kendra Harris

April 7, 2022

Details

Building a Sustainable Radioligand Treatment Clinic – Charlotte Manogue

August 30, 2021

Details

Patient Management and Operationalizing Lutetium-177–PSMA-617 for Metastatic Castration Resistant Prostate Cancer in the Clinic – Charlotte Manogue and Oliver Sartor

August 29, 2021

Details

Establishing A Theranostics Clinic for Advanced Prostate Cancer – Kendra Harris and Charlotte Manogue

August 25, 2021

Details

The Stakeholders in Operationalizing an Integrated PSMA Imaging and Therapies Clinic - Kendra Harris

August 25, 2021

Details